FDA Approves First Drug Aimed at Women With Inherited Breast Cancer (statnews.com)

Posted by msmash on Monday January 15, 2018 @10:05AM from the moving-forward dept.

U.S. regulators have approved the first drug aimed at women with advanced breast cancer caused by an inherited flawed gene. From a report: The Food and Drug Administration on Friday approved AstraZeneca PLC's Lynparza for patients with inherited BRCA gene mutations who have undergone chemotherapy. The drug has been on the market since 2014 for ovarian cancer, and is the first in a new class of medicines called PARP inhibitors to be approved for breast cancer. PARP inhibitors prevent cancer cells from fixing problems in their DNA. Lynparza will cost $13,886 per month without insurance, according to AstraZeneca. The company is offering patients financial assistance.

3 of 33 comments (clear)

Min score:

Reason:

Sort:

$13,886 by Anonymous Coward · 2018-01-15 10:12 · Score: 0, Troll

The company is offering patients financial assistance.
That's really swell.
When are we finally going to lynch these sons-of-bitches?
1. Re:$13,886 by Anonymous Coward · 2018-01-15 10:18 · Score: 0, Troll
  
  They didn't give you cancer. They aren't forcing you to buy the medicine. You could just buy medical insurance to get this all-or-mostly covered.
  Once upon a time, this medicine didn't exist, and you weren't pissed off. Now, a new medicine exists, and new options are available, and you are pissed off.
  Sad.
Great but... by 110010001000 · 2018-01-15 10:12 · Score: 0, Troll

...what about us who don't identify as a binary gender? Rather insensitive and exclusionary.